UltraTech Cement has Market leadership, strong brand with highest retail presence and robust balance sheet: ICICI-Direct
UltraTech Cement has Market leadership, strong brand with highest retail presence and robust balance sheet: ICICI-Direct | |
Company: | Ultratech Cement |
Brokerage: | ICICI-Direct |
Date of report: | July 23, 2021 |
Type of Report: | Result Update |
Recommendation: | Buy |
Upside Potential: | 17% |
Summary: | Margin stays firm; outlook remains healthy… |
Full Report: | Click here to download the file in pdf format |
Tags: | ICICI-Direct, Ultratech Cement |
Margin stays firm; outlook remains healthy… About the stock: UltraTech is the largest cement manufacturer in India with a domestic capacity of 111.4 MT (23% of total market) with a leadership position in most regions (excluding east). It has grown through organic and inorganic routes and added around ~30 MT of capacity in the last three years. It has shown its capability to successfully integrate the acquired assets and ramped-up its utilisations in a profitable manner The company is now focusing on fast growing market of eastern India, which accounts for 10.2 MT of its total 19.6 MT planned expansion over FY21-23E Q1FY22 Results: UltraTech surprised positively on the margin front in Q1FY22 leading to better profitability despite 17.8% QoQ drop in revenues. Clocked revenue of | 11,477 crore, down 17.8% QoQ led by sales volumes de-growth of 22.8% to 20.5 MT. On YoY basis, revenues were up 55.6% EBITDA/t up 17% QoQ to | 1,545/t (vs. last quarter EBITDA/t of | 1321/t). EBITDA margin was at 27.6%, up 249 bps QoQ, 112 bps YoY Ensuing PAT was at | 1,681 crore, up 108.7% YoY, down 5.4% QoQ vs. our estimate: | 1457 crore) What should investors do? Market leadership, strong brand with highest retail presence and robust balance sheet justifies UltraTech’s premium valuations. With a target to become net debt free by FY23E and expected RoCE of 17%+, we remain positive on company. Hence, we maintain BUY rating Target Price and Valuation: We value UltraTech at | 8,700 i.e. 17x FY23E EV/EBITDA Key triggers for future price performance: The new organic capacities are being added at lower capital cost (US$60/t) that will help in boosting return ratios (to generate 16-18% IRR) Despite capex plans, the company also aims to become net debt-free by FY23E supported by strong operating cash flows (from existing and acquired assets) and through efficient w/cap management Alternate Stock Idea: Apart from UltraTech, in our cement sector coverage we also like ACC. It has strong balance sheet with debt frees status. The company is focusing on cost reduction and also adding new capacities via internal accruals |
Leave a Reply